Patent ID: 8562994
Filing Date: 2013-10-22
Classification: A61K,A61P,C07K

Abstract:
1. A method of neutralizing respiratory syncytial virus (RSV), comprising administering to a human in need thereof an effective amount of a humanized anti-RSV antibody comprising (a) a variable heavy chain polypeptide comprising a VH CDR1 comprising the amino acid sequence of SEQ ID NO: 43, a VH CDR2 comprising the amino acid sequence of SEQ ID NO: 44, and a VH CDR3 comprising the amino acid sequence of SEQ ID NO: 45; and (b) a variable heavy chain polypeptide and a variable light chain polypeptide, wherein the variable heavy chain polypeptide sequence is SEQ ID NO:31 and the variable light chain polypeptide sequence is SEQ ID NO:34.